109048 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
Compositions and methods for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression
#8702AGENTS AND METHODS FOR INHIBITING MIR-148A FOR THE MODULATION OF CHOLESTEROL LEVELS
#8703Compositions and methods for induced tissue regeneration in mammalian species
#8704Effective method for specific gene silencing using artificial small RNA
#8705Treating alcohol-mediated disorders by inhibition of RGS6
#8706PEPTIDE-AND AMINE-MODIFIED GLUCAN PARTICLES FOR DELIVERY OF THERAPEUTIC CARGOES
#8707Fidgetin-like 2 as a target to enhance wound healing
#8708Organic small hairpin RNAs
#8709Antisense molecules for treatment of infection
#8710Therapeutic polynucleotides, compositions, and methods
#8711Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field
#8712Methods of Inhibiting Tumorigenesis in Colon Adenocarcinoma and Compositions Therefor
#8713CRISPR-based compositions and methods of use
#8714Methods and compositions for the specific inhibition of HIF-1α by double-stranded RNA
#8715MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
#8716Antisense molecules and methods for treating pathologies
#8717Means and methods for the generation of mammalian producer cells for the production of recombinant proteins
#8718Compositions and methods using capsids resistant to hydrolases
#8719Channel modulators
#8720Antisense molecules for treatment of infection
#8721E. COLI MEDIATED siRNA SILENCING OF AVIAN INFLUENZA IN CHICKENS
#8722MPS peptides and use thereof
#8723System for delivering therapeutic agents into living cells and cells nuclei
#8724Sphingolipid-polyalkylamine-oligonucleotide compounds
#8725AGENT FOR TREATING FIBROSIS OF THE INTESTINE
#8726METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TUMORIGENICITY
#8727NUCLEIC ACID SENSOR FOR MELAMINE ANALYSIS, DEVICE FOR MELAMINE ANALYSIS, AND METHOD FOR MELAMINE ANALYSIS
#8728Gene expression or activity enhancing elements
#8729MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#8730Phased small RNAs
#8731Treatment of Adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an Adiponectin (ADIPOQ)
#8732UNA single stranded oligomers for therapeutics
#8733Methods and compositions using miR-3151 in the diagnosis and treatment of thyroid cancer
#8734Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids
#8735Compositions of ascorbic acid and bone morphogenetic protein 4 (BMP-4) for cell growth and uses related thereo
#8736Genetically modified cells, tissues, and organs for treating disease
#8737Methods and compositions for treating and diagnosing diseases
#8738Modulation of axon degeneration
#8739Methods for suppressing adipocyte differentiation
#8740COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING MUSCULAR DYSTROPHY
#8741TTV miRNA sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention
#8742Polynucleotides for multivalent RNA interference, compositions and methods of use thereof
#8743Formulations comprising antisense nucleotides to connexins
#8744METHODS OF TREATING CANCER AND PREVENTING CANCER DRUG RESISTANCE
#8745Compositions and methods for regulating gene expression via RNA interference
#8746Therapeutic phages and methods for delivery of nucleic acids for therapeutic uses
#8747PROCESSES FOR PRODUCING EXOSOMES IN REDUCED OXYGEN CULTURE CONDITIONS
#8748Inhibition of the synthesis of beta-app or the activity of the A-β peptide in the choroid plexus
#8749Methods and compounds useful in conditions related to repeat expansion
#8750ALKYNE PHOSPHORAMIDITES AND PREPARATION OF SPHERICAL NUCLEIC ACID CONSTRUCTS
#8751NOVEL NANOLIPOSOMES AND THEIR USE FOR THE TREATMENT OF AMYLOID PROTEIN DISEASES
#8752Multi-tailed lipids and uses thereof
#8753PROCESSES FOR PRODUCING STABLE EXOSOME FORMULATIONS
#8754Polyarginine-coated magnetic nanovector and methods of use thereof
#8755Detection and treatment of irritable bowel syndrome
#8756METHOD FOR CELL MEMBRANE PERMEATION FOR COMPOUND
#8757Compositions and methods for efficacious and safe delivery of siRNA using specific chitosan-based nanocomplexes
#8758Compositions and methods for controlled delivery of inhibitory ribonucleic acids
#8759Antisense oligonucleotide compositions
#8760RIG-I ligands and methods for producing them
#8761Method of regulating gene expression
#8762NOVEL COMPOUNDS
#8763Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
#8764ANALYZING METHOD FOR MICRO RNA ID AND BIOMARKERS RELATED TO COLON CANCER THROUGH THIS METHOD
#8765COMPOUND ADMINISTRATION PRECURSOR AND MEDICAMENT CARRIER PREPARATION
#8766METHOD FOR RECOMBINANT PROTEIN PRODUCTION IN MAMMALIAN CELLS
#8767Compounds and methods for modulating apolipoprotein C-III expression for improving a diabetic profile
#8768Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
#8769Low density lipoprotein receptor-mediated siRNA delivery
#8770Compositions and methods for treating alzheimer's disease and other tauopathies
#8771Nucleic acid particles, methods and use thereof
#8772Root-preferred promoter and methods of use
#8773LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME
#8774METHOD FOR THE TARGETED KILLING OF CELLS BY NUCLEOTIDE MOLECULES THAT ARE DIRECTED TO mRNA BINDING, AND ALSO NUCLEOTIDE MOLECULES AND APPLICATION KIT FOR SUCH USE
#8775Oligomers with improved off-target profile
#8776Albumin production and cell proliferation
#8777Compositions for modulating Tau expression
#8778Inhibition of microRNA for treatment of sepsis
#8779AGONISTS OF DDAH1 FOR TREATING ENDOTHELIAL DYSFUNCTION
#8780Double-stranded agents for delivering therapeutic oligonucleotides
#8781Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof
#8782DIAGNOSIS AND TREATMENT OF METABOLIC DISORDERS
#8783Age-related macular degeneration treatment
#8784Compositions and methods for the delivery of nucleic acids
#8785Micro-RNA family that modulates fibrosis and uses thereof
#8786Micro-RNA family that modulates fibrosis and uses thereof
#8787Micro-RNA family that modulates fibrosis and uses thereof
#8788Methods for expressing a polynucleotide of interest in the retina of a subject
#8789ICE-CLEAVED ALPHA-SYNUCLEIN AS A BIOMARKER
#8790Compositions, kits and methods for treatment of cardiovascular,immunological and inflammatory diseases
#8791COMPOSITIONS AND METHODS FOR MODULATING HIV ACTIVATION
#8792CHI3L1 FOR THE DETECTION AND TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
#8793Methods for detecting and treating multiple myeloma
#8794Compositions and methods for delivering nucleic acid to a cell
#8795Identification of a resistance gene from pepper () and method for generating plants with resistance
#8796Oligonucleotide conjugates
#8797Compositions and methods for treating cancer and other diseases
#8798MicroRNA and methods for inhibiting same
#8799Block Decoys
#8800Anti-miR-27b and anti-miR-148a oligonucleotides as therapeutic tools for treating dyslipidemias and cardiovascular diseases
#8801Microrna and uses in brown fat differentiation
#8802Microrna compounds and methods for modulating MIR-21 activity
#8803Antisense oligonucleotides for treatment of cancer stem cells
#8804ANTISENSE COMPOUNDS AND USES THEREOF
#8805Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#8806COLON DISEASE TARGETS AND USES THEREOF
#8807Cationic lipids for therapeutic agent delivery formulations
#8808MICRORNA DOSING REGIMENS
#8809Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#8810Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#8811Artificial DNA sequence with optimized leader function in 5′(5′-UTR) for the over-expression of recombinant proteins in plants and method for the production of recombinant proteins in plants
#8812Interfering RNA molecules
#8813Preventive or therapeutic agent for fibrosis
#8814Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA
#8815Double-stranded antisense nucleic acid with exon-skipping effect
#8816OLIGONUCLEOTIDE MODULATORS OF B-CELL CLL/LYMPHOMA 11A (BCL11A) AND USES THEREOF
#8817TARGETING DOMAIN AND RELATED SIGNAL ACTIVATED MOLECULAR DELIVERY
#8818RNA amidates and thioamidates for RNAi
#8819Adipocyte-targeting non-viral gene delivery system
#8820Reduced size self-delivering RNAi compounds
#8821NUCLEOTIDE SEQUENCE MOTIFS DIRECTING NUCLEIC ACID LOCATION TO EXTRACELLULAR VESICLES
#8822Methods for maturing cardiomyocytes and uses thereof
#8823Compounds and methods for trans-membrane delivery of molecules
#8824Double-stranded ribonucleic acid as control against insects
#8825Methods and compositions for reducing immunosupression by tumor cells
#8826RESPIRATORY DISEASE-RELATED GENE SPECIFIC SIRNA, DOUBLE-HELICAL OLIGO RNA STRUCTURE CONTAINING SIRNA, COMPOSITON CONTAINING SAME FOR PREVENTING OR TREATING RESPIRATORY DISEASE
#8827Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancer
#8828METHODS OF TREATING ATHEROSCLEROSIS
#8829COMPOSITIONS AND METHODS FOR MODULATION OF TARGET NUCLEIC ACIDS
#8830COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION
#8831Dosages and methods for delivering lipid formulated nucleic acid molecules
#8832AGENTS FOR DOWNREGULATION OF THE ACTIVITY AND/OR AMOUNT OF BCL-XL AND/OR BCL-W
#8833SiRNA targeting HSR1
#8834RETRO POLYPEPTIDES FOR ACTIVATION IMMUNITY TO CANCER AND VIRAL INFECTION
#8835TRICYCLIC NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM
#8836COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES
#8837Liposomes for modulating Wiskott-Aldrich syndrome protein
#8838In vitro method of inhibiting the growth of radioresistant laryngeal cancer cells
#8839Methods for identifying agents useful for modulating the expression and aggregation of CAG-expanded gene product in cells
#8840CRISPR-Cas component systems, methods and compositions for sequence manipulation
#8841Dermatological, pharmaceutical composition suitable for oligonucleotides
#8842Lipid encapsulating interfering RNA
#8843Compositions and methods for inhibiting expression of the ALAS1 gene
#8844Treatment of insulin resistance through inhibitors of transcription factor TSC22D4
#8845Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases
#8846Methods for treating inflammatory responses or diseases caused by inflammation using ApoA-I binding protein (APOA1BP)
#8847Hydrophobically modified antisense oligonucleotides comprising a triple alkyl chain
#8848Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#8849Compositions and methods of nucleic acid-targeting nucleic acids
#8850Compositions and methods for insecticidal control of stinkbugs
#8851METHOD OF REGULATING CFTR EXPRESSION AND PROCESSING
#8852Method for inhibiting HIV replication in mammal and human cells
#8853Methods for diagnosing and treating learning or mental disorders
#8854Complement component C5 iRNA compositions and methods of use thereof
#8855Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression
#8856Modulation of HSP47 expression
#8857Hydrophobically modified antisense oligonucleotides comprising a ketal group
#8858Targeting microRNAs for the treatment of fibrosis
#8859OLIGOMERS TARGETING HEXANUCLEOTIDE REPEAT EXPANSION IN HUMAN C9ORF72 GENE
#8860CHIMERIC SINGLE-STRANDED ANTISENSE POLYNUCLEOTIDES AND DOUBLE-STRANDED ANTISENSE AGENT
#8861Inflammatory disease diagnosis and methods of treatment using lipopolysaccharides-responsive beige-like anchor
#8862Therapeutics for the induction of endogenous steroidogenesis and methods associated with their identification
#8863Antisense antibacterial compounds and methods
#8864Compounds and methods for trans-membrane delivery of molecules
#8865Lipids and lipid compositions for the delivery of active agents
#8866NEUROTENSIN-INDUCED TUMOR FORMATION IS REGULATED BY MICRO RNA 133A-AFTIPHILIN-DEPENDENT RECEPTOR RECYCLING
#8867Compositions and methods for inhibiting expression of the HAMP gene
#8868Protection against ionizing radiation and chemotherapy toxicity via latexin regulation
#8869miR-96-5p INHIBITOR AND A SCREENING METHOD FOR THE INHIBITOR
#8870IN VIVO PRODUCTION OF SMALL INTERFERING RNAS THAT MEDIATE GENE SILENCING
#8871COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR OXIDATIVE STRESS AND RETINITIS PIGMENTOSA
#8872Oligonucleotide analogues targeting human LMNA
#8873Method of isolating nucleic acid
#8874Recurrent gene fusions in prostate cancer
#8875Methods for multiplexing recombinase polymerase amplification
#8876Methods for diagnosis and treatment of amyotrophic lateral sclerosis based on an increased level of interaction between TDP-43 polypeptide and NF-KB P65 polypeptide
#8877COMPOSITION FOR EXTERNAL APPLICATION COMPRISING TRANSCRIPTION FACTOR DECOY AS ACTIVE INGREDIENT
#8878Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
#8879Antisense compounds and uses thereof
#8880Methods to prevent and treat autosomal dominant non-syndromic hearing loss
#8881Compositions and methods for modulating apolipoprotein (a) expression
#8882Compositions and methods for modulating apolipoprotein C-III expression
#8883Composition and method for inner ear sensory hair cell regeneration and replacement
#8884Lipid Formulated Compositions And Methods For Inhibiting Expression Of Transthyretin (TTR)
#8885Use of MicroRNA or inhibitors thereof in regulation of lipid metabolism
#8886Regulator targetting fatty acid synthase and method of using the same for improving meat quality
#8887Synthetic lethality in cancer
#8888Phase changing formulations of nucleic acid payloads
#8889Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
#8890MiRNA for regulating FABP6 gene and method of using the same
#8891Compositions and methods for the treatment of parkinson disease by the selective delivery of oligonucleotide molecules to specific neuron types
#8892Prophylactic and/or therapeutic agent for inflammatory disease, and method for screening prophylactic and/or therapeutic drug for inflammatory disease
#8893COMPOSABILITY AND DESIGN OF PARTS FOR LARGE-SCALE PATHWAY ENGINEERING IN YEAST
#8894METHODS, SYSTEMS, AND COMPOSITIONS RELATING TO TREATMENT OF NEUROLOGICAL CONDITIONS, DISEASES, AND INJURIES AND COMPLICATIONS FROM DIABETES
#8895SiRNA TARGETING ETS1 AND ELK1 AND METHOD OF USING SAME IN THE INHIBITION OF CIP2A GENE IN CANCER TREATMENT
#8896Oligonucleotide lipid nanoparticle compositions, methods of making and methods of using the same
#8897Small Interfering RNA Delivery
#8898Foreign DNA surveillance protein
#8899Therapeutic compositions
#8900Pharmaceutical composition for treating liver diseases
#8901Morpholino oligonucleotide manufacturing method
#8902Compositions and methods
#8903Phosphorous-linked oligomeric compounds and their use in gene modulation
#8904Compositions and methods for modulating HBV expression
#8905siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
#8906Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs
#8907Compositions and methods for modulation nucleic acids through nonsense mediated decay
#8908DIAGNOSTIC AND THERAPEUTIC METHODS RELATING TO MICRORNA-144
#8909NOVEL SINGLE CHEMICAL ENTITIES AND METHODS FOR DELIVERY OF OLIGONUCLEOTIDES
#8910Peptide-mediated intravesical delivery of therapeutic and diagnostic agents
#8911Hydrazinyl lipidoids and uses thereof
#8912Methods of identifying compounds for the treatment of fibrosis by using S1PR5
#8913Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cells
#8914METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#8915Modulation of dystrophia myotonica-protein kinase (DMPK) expression
#8916miR-29 mimics and uses thereof
#8917Cancer treatment methods using remote conditioning
#8918RNAI MODULATION OF SCAP AND THERAPEUTIC USES THEREOF
#8919Metal-ligand coordination polymer nanoparticles and methods for making
#8920SMN2 element 1 antisense compositions and methods and uses thereof
#8921Short interfering nucleic acid (siNA) molecules containing a 2′ internucleoside linkage
#8922Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#8923Composition for delivery of genetic material
#8924Fungal immunogens and related materials and methods
#8925BIOACTIVE APOLAR EXTRACT CONTAINING PLANT GENETIC MATERIAL FOR TREATMENT OF MAMMALIAN DISEASES
#8926Hydrazinyl lipidoids and uses thereof
#8927Treatment of inflammatory diseases
#8928Compositions and Methods for Evaluating Heart Failure
#8929METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#8930Method for treating breast cancer by targeting breast cancer stem cell
#8931Method for evaluating redox activity of nucleic acid molecule and nucleic acid molecule having redox activity
#8932Synthetic mimics of miR-124
#8933Down-regulating gene expression in insect pests
#8934Pharmaceutical Composition for Inhibition of Disease-inducing microRNAs
#8935MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION
#8936MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION
#8937Huntington's disease therapeutic compounds
#8938METHOD OF REGULATING NFATC2 ACTIVITY IN LYMPHOCYTES
#8939PREVENTION OF MUSCULAR DYSTROPHY BY CRISPR/CAS9-MEDIATED GENE EDITING
#8940Lipopeptides for delivery of nucleic acids
#8941MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF FIBROTIC DISEASES
#8942Genetic amplification of IQGAP1 in cancer
#8943MICRO-RNAS MODULATING IMMUNITY AND INFLAMMATION
#8944RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#8945Multi-targets interfering RNA molecules and their applications
#8946SYNTHETIC MIMICS OF MIR-34
#8947Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA
#8948Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
#8949Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
#8950Biocompatible infinite coordination polymer nanoparticle-nucleic acid conjugates for antisense gene regulation
#8951Double stranded RNA constructs for aphid control
#8952Composition for controlling stem cells pluripotency, containing LIN28A methylation inhibitor, and method for screening for LIN28A methylation inhibitor
#8953Method for assaying microRNA, cancer therapeutic agent, and medicinal composition containing same for cancer therapy
#8954COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN
#8955Treatment of genetic disorders associated with DNA repeat instability
#8956Compositions and methods for treating HIF-1α over-expressing cancers
#8957Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#8958COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A THERAPEUTIC AGENT TARGETING COMPLEMENT C5
#8959Kit with stabilized thrombin
#8960Materials and Methods Useful For Affecting Tumor Cell Growth, Migration and Invasion
#8961Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG
#8962Targeting microRNAs for the treatment of liver cancer
#8963Targeting microRNAs for metabolic disorders
#89645′ modified nucleosides and oligomeric compounds prepared therefrom
#8965HAMMERHEAD RIBOZYMES
#8966Small interference RNA for inhibiting intracellular expression of ribosomal protein S3
#8967Biodegradable and clinically-compatible nanoparticles as drug delivery carriers
#8968HSA-MIR-146B-5P-related nucleic acids and uses thereof
#8969Signal activated RNA interference
#8970Modulators of alpha-synuclein toxicity
#8971Site-specific induction of bimolecular quadruplex-duplex hybrids and methods of using the same
#8972Methods for enhancing utrophin production via inhibition of microRNA
#8973Method for inhibiting proliferation of high LIX1L-expressing tumor cell, and tumor cell proliferation-inhibiting peptide
#8974Inhibition of choroidal neovascularization
#8975Compositions and Methods for Delaying Senescence in Cut Flower
#8976ApoIII and the Treatment and Diagnosis of Diabetes
#8977CIS-blocked guide RNA
#8978IRES elements for expression of polypeptides and methods of using the same
#8979Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient
#8980DNAI FOR THE MODULATION OF GENES
#8981EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#8982In vivo delivery of oligonucleotides
#8983Modulation of RNA activity and vascular permeability
#8984siRNA-mediated gene silencing
#8985Biological Materials and Uses Thereof
#8986Modified Poly(Beta-Amino Ester)s for Drug Delivery
#8987CARRIER THAT TARGETS FUCOSYLATED MOLECULE-PRODUCING CELLS
#8988MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS
#8989Non-liposomal systems for nucleic acid delivery
#8990Controlling fungal pathogens by disabling their small RNA pathways using RNAi-based strategy
#8991Pharmaceutical composition comprising Nanog shRNA, and method of using Nanog shRNA to treat cancer
#8992Oral delivery of therapeutically effective LNA oligonucleotides
#8993RNA sequence-specific mediators of RNA interference
#8994Method of deriving mature hepatocytes from human embryonic stem cells
#8995Inhibitors of MYH7B and uses thereof
#8996Compositions and methods for modulating Tau expression
#8997ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
#8998Random RNAi libraries, methods of generating same, and screening methods utilizing same
#8999Role for the perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway
#9000Methods for Promoting Reinnervation of Auditory Hair Cells